Neogen Chemicals Ltd. · NSE:NEOGEN
Neogen Chemicals — Q4 FY2019 Earnings Presentation
16 slides from Neogen Chemicals's earnings presentation, May 27, 2019
Slide 1: Neogen Chemicals Ltd. Q4 & FY19 Earnings Presentation
Neogen Chemicals Ltd. Q4 & FY19 Earnings Presentation May 27, 2019
Slide 2: Safe Harbour
Safe Harbour 2 Certain statements in this document may be forward-looking statements. Such forward looking statements are subject to certain risks and uncertainties like regulatory changes, local political or economic developments, and many other factors that could cause our actual results to differ
Slide 3: Table of Contents
Table of Contents 3 1 2 3 4 5 6 7 8 Financial Key Introduction Table – Balance Historical Competitive Performance Management Way to Neogen Profit & Sheet Financial Advantages Highlights – Commentary Forward Chemicals Loss Snapshot Performance Q4 & FY19 Statement
Slide 4: Neogen Chemicals – At a Glance
Neogen Chemicals – At a Glance 4 Leading manufacturer of Bromine and Lithium-based specialty chemicals, operating since 1991 Products developed Of workforce in Strong portfolio of Organic and Inorganic products by in-house R&D R&D team Customers across multiple industries including Pharma, Engineeri
Slide 5: Business Overview and Clientele
Business Overview 5 Organic Chemicals Inorganic Chemicals The portfolio includes specialty, inorganic Custom Synthesis & lithium-based chemical products which Bromine Compounds Advanced Intermediates Manufacturing find applications across multiple industries Organic compounds containing Combining br
Slide 6: Competitive Advantages
Competitive Advantages 6 Large and diverse array of products Strong Manufacturing Capabilities Experienced promoters with domain knowledge Diversified and Stable Established and stable Customer Base relationship with suppliers Specialised Business Model Continuous Investment with high entry barriers
Slide 7: Key Performance Highlights – Q4 & FY2019
Key Performance Highlights – Q4 & FY2019 7 FY19 Q4 FY19 FY19 Revenue ` 239 cr 46% ` 80 cr 35% break-up Revenues ` 43 cr 50% ` 16 cr 40% EBITDA 49% 51% ` 29 cr 67% ` 12 cr 39% Profit Before Tax ` 21 cr 97% ` 9 cr 27% Domestic Exports* Profit After Tax Note: Growth for FY19 is compared to FY18 and gro
Slide 8: Financial Summary – FY2019
Financial Summary – FY2019 8 REVENUE EBITDA PAT 43 21 239 164 29 11 FY18 FY19 FY18 FY19 FY18 FY19 Rs. crore Rs. crore Rs. crore Strong revenue growth was EBITDA expanded on Profit After Tax improved led by combination of factors account of: due to: including: • Better Capacity utilization • Strong o
Slide 9: Revenue break-up – FY2019
Revenue break-up – FY2019 9 FY2019 FY2018 82% Rs. 193 cr. Rs. 106 cr. Robust growth was driven by higher Organic capacity utilisation and better Chemicals efficiency of operations Subdued growth was a result of lower Inorganic prices of lithium RM as well as softer Chemicals demand from customers (1
Slide 10: Financial Table – Profit & Loss Statement (Standalone)
Financial Table – Profit & Loss Statement (Standalone) 10 Particulars (Rs. crore) Q4 FY2019 Q4 FY2018 Growth (%) FY2019 FY2018 Growth (%) Revenue 79.8 58.9 35% 239.1 164.0 46% Expenditure 63.5 47.3 34% 195.6 135.0 45% EBITDA 16.3 11.6 40% 43.4 29.0 50% Margins 20.4% 19.7% 18.2% 17.8% Depreciation 0.
Slide 11: Balance Sheet Snapshot (Standalone)
Balance Sheet Snapshot (Standalone) 11 Particulars (Rs. In crore) As on March 31, 2019 As on March 31, 2018 Assets Non-current assets 86.6 73.7 Current assets 160.1 106.9 Total Assets 246.7 180.6 Liabilities Shareholders' Funds 70.5 50.6 Non-current liabilities 59.5 46.4 Current liabilities 116.7 83
Slide 12: Management Commentary
Management Commentary 12 Commenting on the performance, Mr. Haridas Kanani, Chairman & Managing Director at Neogen Chemicals said: “I am pleased to share our first financial and operational performance as a listed company after successfully concluding the IPO. I also humbly welcome on board all our
Slide 13: Historical Financial Performance
Historical Financial Performance 13 Net Revenue from Operations** EBITDA (INR crore) Margin (%) (INR crore) 18.1% 17.8% 18.2% 15.4% 15.0% 14.0% 239 163 101 111 74 85 12 13 14 20 29 43 FY14 FY15 FY16 FY17 FY18 FY19 FY14 FY15 FY16 FY17 FY18 FY19 ** Revenue is Net of Excise PAT (INR crore) Margin (%) N
Slide 14: Way Forward
Way Forward 14 Focus on Expanding operational production efficiency and capacities Focus on advanced speciality functional Augmenting excellence Increasing growth in domestic intermediates Custom Synthesis and global markets & Manufacturing portfolio
Slide 15: About Us
About Us 15 Incorporated in 1991, Neogen Chemicals Ltd. (NSE Code: NEOGEN; BSE For further information, please contact: Code: 542665) is one of India’s leading manufacturers of Bromine-based and Lithium-based specialty chemicals. It’s specialty chemicals product offerings comprise of Organic as well
Slide 16: Thank You
3 ) > x ca (ar) = al